Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atopic Hypersensitivity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06551363
What this trial is testing

Atopic Dermatitis Cutaneous Discomfort of the Infant Under the Age of One Year : Analysis of Filmed Sequences (PRE-PRURINEO)

Who this might be right for
Atopic Dermatitis
University Hospital, Brest 7
Not applicableUnknownNCT05578716
What this trial is testing

Growth, Allergy and Neurodevelopment in Infants on Hydrolysed Formula

Who this might be right for
Infant Formula
Umeå University 312
Not applicableStudy completedNCT01074164
What this trial is testing

Acupressure in Pruritus for Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Northwestern University 15
Not applicableWithdrawnNCT01691209
What this trial is testing

Efficacy/Safety Study to Explore a New Topical Formulation in Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Bayer
Large-scale testing (Phase 3)Study completedNCT06224192
What this trial is testing

A Study With Self-administered Rocatinlimab in Adolescent and Adult Participants With Moderate-to-severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Amgen 151
Testing effectiveness (Phase 2)Study completedNCT05656911
What this trial is testing

Learn How Well the Study Treatment Zabedosertib (BAY1834845) Works and How Safe it is Compared to Placebo in Adult Participants With Moderate-to-severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Bayer 77
Testing effectiveness (Phase 2)Study completedNCT04539639
What this trial is testing

Clinical Study of Jaktinib in the Treatment of Patients With Moderate and Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 166
Early research (Phase 1)Study completedNCT06553209
What this trial is testing

Study of CM512 in Healthy Subjects and Patients With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Keymed Biosciences Co.Ltd 110
Post-approval studies (Phase 4)Study completedNCT04033367
What this trial is testing

SAR231893-LPS15497- "Dupilumab Effect on Sleep in AD Patients"

Who this might be right for
Atopic Dermatitis
Sanofi 188
Testing effectiveness (Phase 2)Study completedNCT06790121
What this trial is testing

Investigate the Efficacy and Safety of Subcutaneous Lunsekimig (SAR443765) Compared With Placebo in Adult Participants With Moderate-to-severe Atopic Dermatitis

Who this might be right for
Dermatitis Atopic
Sanofi 150
Large-scale testing (Phase 3)Looking for participantsNCT06389136
What this trial is testing

Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

Who this might be right for
Atopic Dermatitis
AbbVie 200
Testing effectiveness (Phase 2)UnknownNCT05671445
What this trial is testing

The Study of CM326 in Adult Subjects With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Keymed Biosciences Co.Ltd 100
Not applicableEnrolling By InvitationNCT07503197
What this trial is testing

A Study on the Efficacy of 2% Cholesterol Cream in Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)CholesterolSkin Barrier to Water Loss+3 more
Institute of Dermatology, Thailand 30
Testing effectiveness (Phase 2)Study completedNCT03250624
What this trial is testing

Safety and Efficacy of CD5024 0.3% Cream in Subjects With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Galderma R&D 63
Not applicableStudy completedNCT03863418
What this trial is testing

Probiotic Lactobacillus Rhamnosus GG for Pediatric Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Federico II University 100
Early research (Phase 1)Study completedNCT06342713
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035 in Healthy Participants and in Adults With Autoimmune Dermatological Diseases

Who this might be right for
Healthy ParticipantsHealthy SubjectsHealthy Volunteers+4 more
BeiGene 203
Testing effectiveness (Phase 2)Study completedNCT01859988
What this trial is testing

Study of Dupilumab Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Regeneron Pharmaceuticals 380
Testing effectiveness (Phase 2)Study completedNCT00146003
What this trial is testing

Efalizumab for Eczema

Who this might be right for
Dermatitis, Atopic
University of Medicine and Dentistry of New Jersey 10
Post-approval studies (Phase 4)Study completedNCT05642208
What this trial is testing

Dupilumab Step-down Strategy to Maintain Remission in Adult and Adolescents Patients With Atopic Dermatitis

Who this might be right for
Atopic DermatitisEczema, Atopic
Nantes University Hospital 256
Large-scale testing (Phase 3)Study completedNCT03796676
What this trial is testing

JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Pfizer 287
Next Page